Search research articles
Contact Us
Filters
Showing results (191-200 of 338) with videos related to
Page
of 34
Sort By:
NPJ Precision Oncology
|
March 2, 2023
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Eleni Gkika, Elke Firat, Sonja Adebahr, et al.
Neuro-Oncology
|
September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy
Bocheng Wu, Subhasish Tapadar, Zhiping Ruan, et al.
Journal of Neuro-Oncology
|
September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide
Elizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.
Journal of the National Cancer Institute
|
March 15, 2022
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma
Hiroto Kikuchi, Aya Matsui, Satoru Morita, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2025
IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesity
Nilesh P Talele, Heena Kumra, Igor L Gomes-Santos, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia
|
March 1, 1995
[The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo]
V I Metelitsa, S G Duda, V M Gorbunov, et al.
Kardiologiia
|
January 1, 1993
[Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy]
V I Metelitsa, S G Duda, T P Ostrovskaia, et al.
Biorxiv : the Preprint Server for Biology
|
March 17, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma
Xin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Page
of 34
Search research articles
Search
Showing results (191-200 of 338) with videos related to
Sort By:
Page
of 34
NPJ Precision Oncology
|
March 2, 2023
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Eleni Gkika, Elke Firat, Sonja Adebahr, et al.
Neuro-Oncology
|
September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy
Bocheng Wu, Subhasish Tapadar, Zhiping Ruan, et al.
Journal of Neuro-Oncology
|
September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide
Elizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.
Journal of the National Cancer Institute
|
March 15, 2022
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma
Hiroto Kikuchi, Aya Matsui, Satoru Morita, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2025
IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesity
Nilesh P Talele, Heena Kumra, Igor L Gomes-Santos, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia
|
March 1, 1995
[The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo]
V I Metelitsa, S G Duda, V M Gorbunov, et al.
Kardiologiia
|
January 1, 1993
[Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy]
V I Metelitsa, S G Duda, T P Ostrovskaia, et al.
Biorxiv : the Preprint Server for Biology
|
March 17, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma
Xin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Page
of 34